Day One Biopharmaceutical Stock (NASDAQ: DAWN) stock price, news, charts, stock research, profile.
Open | $16.340 |
Close | $16.000 |
Volume / Avg. | 734.965K / 1.077M |
Day Range | 15.920 - 16.660 |
52 Wk Range | 9.670 - 18.070 |
Market Cap | $1.398B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 51 |
Short Interest | 12.77% |
Days to Cover | 12.8 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Day One Biopharmaceutical (NASDAQ: DAWN) through any online brokerage.
Other companies in Day One Biopharmaceutical’s space includes: Gyre Therapeutics (NASDAQ:GYRE), 4D Molecular Therapeutics (NASDAQ:FDMT), Immatics (NASDAQ:IMTX), Prothena Corp (NASDAQ:PRTA) and Xencor (NASDAQ:XNCR).
The latest price target for Day One Biopharmaceutical (NASDAQ: DAWN) was reported by HC Wainwright & Co. on Tuesday, May 7, 2024. The analyst firm set a price target for 40.00 expecting DAWN to rise to within 12 months (a possible 150.00% upside). 21 analyst firms have reported ratings in the last year.
The stock price for Day One Biopharmaceutical (NASDAQ: DAWN) is $15.9999 last updated May 10, 2024 at 5:52 PM EDT.
There are no upcoming dividends for Day One Biopharmaceutical.
Day One Biopharmaceutical’s Q2 earnings are confirmed for Monday, August 5, 2024.
There is no upcoming split for Day One Biopharmaceutical.
Day One Biopharmaceutical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.